Drugs for nausea and vomiting Flashcards
Antiemetics examples (7)
1) Serotonin 5-HT3 antagonists
2) Corticosteroids
3) Neurokinin receptor antagonists
4) Dopamine receptor antagonists
5) Muscarinic receptor antagonists
6) H1 histamine receptor antagonists
7) Benzodiazepines
Cause of vomiting (4)
- area of POSTREMA of the floor of the fourth ventricle (no BBB) - detection of noxious substance in blood by chemoreceptor trigger zone
- GI tract - detection of noxious substance/ distention during bloating by chemoreceptors/ mechanical receptors
- vestibular system - detect motion (cause of motion sickness)
- higher centres of CNS - detect pain, mood, anxiety etc
most suitable drugs for LOW risk ACUTE nausea & vomiting from CHEMOTHERAPY
1 5HT3 antagonist
OR
2. DEX (corticosteroids)
OR
3. DOP (dopamine receptor antagonist)
most suitable drug for MODERATE risk ACUTE N&V from CHEMOTHERAPY
- 5HT3 antagonist + dexamethasone
most suitable drug for HIGH risk ACUTE N&V from CHEMOTHERAPY/ CARBOPLATIN
5HT3 antagonist + dexamethasone + NK1-receptor antagonist
serotonin 5-HT3 antagonists examples
ONDANSETRON, Granisetron, palonosetron; “-setron”
Name an example of (1) a first-generation and (2) a second-generation 5-HT3 antagonist anti-emetic. State the half-life of these drugs.
(1) First-generation:
* Ondansetron (half-life 4-9 hrs)
(2) Second-generation:
Granisetron: half-life 9-12 hrs in cancer patients
Palonosetron: half-life 40-50 hrs
5HT3 antagonist MOA
- block 5HT3 in GIT, prevents vomiting signals to be transmitted from GIT to CNS
indications for 5HT3 receptor antagonists
- prevent acute CHEMOTHERAPY induced vomiting (not for delayed N&V >24)
- any nausea caused by noxious GIT stimulation, eg small bowel obstruction
5HT3 antagonist dosage for chemotherapy induced vomiting prevention
- IV 30mins before
OR - oral 1 hour before
adverse effects of 5HT3 antagonist
- headache, dizziness, drowsiness
- constipation OR diarrhea
- SMALL risk for cardiac arrhythmia
- AVOID in 1st trimester of pregnancy (orofacial malformation)
DDI for 5HT3 antagonist
- extensively metabolized by CYP450 enzymes
Corticosteroids examples
DEXAMETHASONE, methylprednisolone
corticosteroid MOA
- Mimic effects of endogenous cortisol, MOA unknown
corticosteroid indications
– used in combination with 5-HT3 antagonists to prevent acute and delayed nausea and vomiting in patients on moderately to highly emetogenic CHEMOTHERAPY regimens
adverse effects of corticosteroids
- iatrogenic cushing’s syndrome at high dose/ LT use
dopamine receptor antagonist example
METOCLOPRAMIDE
dopamine receptor antagonists MOA
- block D2 receptor in the chemoreceptor trigger zone (CTZ)
- prokinetic -> stimulate GI motility (useful for impaired bowel movement)
dopamine receptor antagonist indications
- nausea triggered by toxin in blood (CTZ detection)
- impaired bowel movement (CANNOT USE FOR COMPLETE OBSTRUCTION)
dopamine receptor antagonist adverse effects
Extrapyramidal side effects:
- Restlessness, dystonia, and parkinsonian symptoms
- LT -> irreversible tardive dyskinesia (thus only used for ST)
Elevated prolactin levels causing:
- Galactorrhoea, menstrual disorders, gynaecomastia, impotence
neurokinin (NK1) receptor antagonist examples (aka substance P antagonists)
APREPITANT (oral), fosaprepitant (IV); “-pitant”
fosaprepitant is prodrug of aprepitant
NK1 receptor antagonist MOA
- act at NK1 receptor in chemoreceptor trigger zone
NK1 receptor antagonist indication
combine with corticosteroid + 5-HT3 receptor antagonists to
prevent ACUTE and DELAYED n&v caused by highly emetogenic chemotherapy
NK1 antagonist adverse effects
- fatigue, dizziness, diarrhoea
DDI:
- metabolised by CYP3A4 -> interact with various chemotherapeutic agents
most suitable drug for HIGH risk DELAYED n&v from CHEMOTHERAPY
- DEX + OLZ (olanzapine)/ MCP (metoclopramide)/ ACR (aprepitant)
antipsychotics: mixed dopamine/ muscarinic/ histamine receptor antagonist examples (3)
Phenothaizines
- PROCHLORPERAZINE, promethazine (dopamine & muscarinic antagonist + antihistamine)
Butyrophenones:
- DROPERIDOL (dopamine receptor antagonism and weak histamine receptor antagonism)
Atypical antipsychotic
- OLANZAPINE (dopamine, muscarinic & histamine receptor antagonism)
antipsychotics MOA
- dopamine receptor antagonism -> chemoreceptor trigger zone
- muscarinic antagonism -> vomiting center & vestibular system
- antihistamine -> vomiting center & vestibular system, less impt)
antipsychotics adverse effects
– Sedative (due to antihistaminergic effects)
– Extrapyramidal syndrome [EPS]
– Hypotension
– Droperidol: prolongation of the QT interval
most suitable drug for ANTICIPATORY n&v
benzodiazepines
benzodiazepines examples
LORAZEPAM, diazepam
benzodiazepines MOA
- binding to an allosteric site on GABAA receptors increases chloride conductance
- anxiolytic
- reduce anticipatory vomiting or vomiting caused by anxiety
benzodiazepine adverse effects
- sedative / hypnotic; additive effects with other sedative drugs and CNS depressants e.g., antidepressants, alcohol and opioids
- respiratory depression on overdose
- AVOID during first trimester (risk of cleft palate)
drugs used for treatment of motion sickness (2)
muscarinic antagonist
- scopolamine (HYOSCINE), diphenhydramine
hyoscine MOA
- antimuscarinic -> act on vestibular system and vomiting center
- antispasmodic due to muscarinic antagonism -> use for abdominal cramps
hyoscine indications
- prevent motion sickness
- abdominal cramps
hyoscine adverse effects
- dry mouth, blurring of vision
- sedation, confusion
diphenhydramine MOA
- mixed h1 antihistamine (vomiting centre input and vestibular system) & M1 muscarinic receptor antagonist (vomiting center and vestibular system)
diphenhydramine adverse effects
- Sedative (H1 receptor antagonism)
Anticholinergic adverse effects:
- Dry mouth, blurring of vision, constipation